2018-05-28 12:42 IRRAS AB – Q1 Report 2018 – invitation to conference call and webcast IRRAS AB (NASDAQ Stockholm: IRRAS), a publicly-traded, commercial-stage medical technology company focused on developing and commercializing innovative solutions […]
2018-05-24 19:06 Announcement from Xbrane Biopharma's annual general meeting Press release 2018-05-24 The annual general meeting (“AGM“) of Xbrane Biopharma AB (“Xbrane” or the “Company“) was held […]
2018-05-24 13:02 Funding from Vinnova for risk waste containers made of the biocomposite OrganoComp® OrganoClick has been granted SEK 1.4 million from Vinnova for establishing pilot production and making a full size […]
2018-05-23 14:42 Record day for free warrants of series TO4B as well as information about period for exercising warrants of series TO4B Record day for the warrants of series TO4B 2018/2023 issued by Episurf Medical AB (publ) (“Episurf”) to its […]
2018-05-23 07:34 Episurf Medical continues preparations for its US IDE study by appointing Dr Michael A Kelly as special study advisor Episurf Medical (NASDAQ: EPIS B) is approaching the filing of its application to conduct an IDE study in […]
2018-05-22 10:34 European patent approval for Episurf Medical’s individualised surgical instruments The European patent office EPO has announced its intention to grant another European patent for Episurf Medical (NASDAQ: […]
2018-05-21 13:37 Episurf Medical to present at Redeye Growth Day, held in Stockholm, June 4 Episurf Medical will present at Redeye Growth Day, a small-cap investor conference, held in Stockholm on June 4 […]
2018-05-18 12:16 Episurf Medical to present at Småbolagsdagen, held in Stockholm, June 11 Episurf Medical will present at Småbolagsdagen, a small-cap investor conference, held in Stockholm on June 11 (Sheraton Stockholm […]
2018-05-18 11:56 Diamorph AB: Annual Report 2017 As of May 18, 2018 at 08.00, the company’s annual report for 2017 is available on https://diamorph.com/investor/. The […]
2018-05-18 11:47 Diamorph AB: Interim Report First Quarter 2018 As of May 18, 2018 at 08.00, the company’s interim report for the first quarter of 2018 is […]
2018-05-16 11:28 Episurf Medical will exhibit at the 19th EFORT Congress, held in Barcelona, Spain, on May 30 – June 1 Episurf Medical (NASDAQ: EPIS B) will exhibit at the 19thEFORT Congress, Europe’s largest orthopaedic conference, held in Barcelona, […]
2018-05-14 08:50 Management group changes in Episurf Medical Ladan Amiri, Head of Quality and Regulatory Affairs at Episurf Medical, has decided to pursue other opportunities outside […]
2018-05-11 07:12 Episurf Medical and Xbrane Biopharma invites to a company presentation held in Stockholm, May 29 Episurf Medical and Xbrane Biopharma invites to a company presentation held at Episurf Medical’s office at Karlavägen 60 […]
2018-05-11 07:11 IRRAS publishes the 2017 Annual Report Stockholm, Sweden, May 11, 2018 – IRRAS AB (NASDAQ Stockholm: IRRAS), a commercial-stage medical technology company focused on […]
2018-05-09 07:26 IRRAS appoints Dr. Christos Panotopoulos to new role as Special Advisor and a member of the IRRAS Clinical Advisory Board IRRAS appoints Dr. Christos Panotopoulos to new role as Special Advisor and a member of the IRRAS Clinical […]
2018-05-09 06:48 IRRAS announces receipt of updated ISO 13485:2016 certificate and updated CE marks valid until 2021 for two of three IRRAflow™ products Remaining CE mark expected in the near future Stockholm, Sweden May 9, 2018 – IRRAS AB (NASDAQ Stockholm: […]
2018-05-03 20:30 Resolutions at Organoclick's Annual General Meeting 2018 OrganoClick AB (publ) held its Annual General Meeting, 3 May 2018 at the company’s head office in Täby where the […]
2018-05-03 15:00 Notice to Attend the Annual General Meeting of IRRAS AB (publ) The shareholders in IRRAS AB (publ), reg. no. 556872-7134, are hereby invited to attend the annual general meeting […]
2018-05-03 07:33 Episurf Medical will exhibit at the 18th ESSKA Congress, held in Glasgow, Scotland, UK, on May 9-12 Episurf Medical (NASDAQ: EPIS B) will exhibit at the 18thESSKA Congress, Europe’s largest orthopaedic conference for the knee, […]
2018-05-03 07:29 Episurf Medical AB (publ) acquires financing of SEK 7 million by issuing convertible notes and warrants Episurf Medical AB (publ) (“Episurf”) acquires financing of 7 MSEK within the agreement signed with European Select Growth […]
2018-05-02 15:00 Promising clinical results from use of Episealer® accepted for presentation at the 35th AGA Congress in Austria The presentation “Patient-specific miniature surface replacement in refractory focal (osteo) chondral knee joint lesions of the middle-aged patient […]
2018-04-27 08:24 Episurf Medical: Interim Report 1 January - 31 March 2018 First quarter 2018, compared to 2017, Group Group net sales increased by 135% to SEK 1.1m (0.5) Gross […]
2018-04-27 08:21 Xbrane Biopharma publishes 2017 Annual Report Press release 2018-04-27 Xbrane Biopharma AB’s annual report for 2017 is now available at the company’s website, www.xbrane.com. The […]
2018-04-26 08:29 Episurf Medical enters into distribution agreement in Hong Kong and establishes subsidiary in the US Episurf Medical (NASDAQ: EPIS B) today announces that the company has entered into a distribution agreement in Hong […]
2018-04-25 08:30 Notice of annual general meeting in Xbrane Biopharma AB Published: 08:30 CEST 25-04-2018 /GlobeNewswire /Source: Xbrane Biopharma AB / : XBRANE /ISIN: SE0007789409 Notice of annual general […]
2018-04-20 16:56 Episurf Medical will exhibit at the Swedish Sports Medicine Spring Meeting (Idrottsmedicinska Vårmötet), held in Stockholm, Sweden, on April 26-27 Episurf Medical (NASDAQ: EPIS B) will exhibit at Swedish Sports Medicine Spring Meeting, an orthopaedic conference held in […]
2018-04-10 15:11 Episurf Medical will exhibit at the 2nd World Arthroplasty Congress, held in Rome, Italy, on April 19-21 Episurf Medical (NASDAQ: EPIS B) will exhibit at the 2ndWorld Arthroplasty Congress, an orthopaedic conference held in Rome, […]
2018-04-09 10:15 Summary from Annual General Meeting of Episurf Medical AB (Publ) The shareholders of Episurf Medical AB (publ) (“Episurf” or the “Company”) gathered in Stockholm, Sweden, on Monday 9 April […]
2018-04-04 06:06 Announcement from Xbrane Biopharma's extra general meeting Press release 2018-04-03 The extra general meeting (“EGM“) of Xbrane Biopharma AB (“Xbrane Biopharma” or the “Company“) was […]
2018-04-03 12:06 Episurf Medical’s knee products approved for marketing and sale in Spain Episurf Medical (NASDAQ: EPIS B) today announces that the Spanish authority AEMPS (Agencia Española de Medicamentos y Productos […]
